Mera Pharmaceuticals, Inc. (MRPI)
Mera Pharmaceuticals, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Las Vegas, NV, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $55,730. On trailing twelve-month figures it carries a trailing P/E of -10000.00, a net margin of 0.0%. Its beta of 1.24 implies it has historically moved more than the broad market.
Mera Pharmaceuticals, Inc. focuses on the development and commercialization of natural products from microalgae using its proprietary and large-scale photobioreactor technology. The company is also involved in the development of sea salt; and operation of family entertainment center focused on promoting health and wellness through the Villari’s system of martial arts. In addition, it provides food production and delivery services. Mera Pharmaceuticals, Inc. was founded in 1983 and is based in Las Vegas, Nevada.
Mera Pharmaceuticals, Inc. is most often compared with the following Healthcare names: